CompletedPhase 1NCT00655655
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Studying Zollinger-Ellison syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Julian R. Molina, M.D., Ph.D.Mayo Clinic
- Intervention
- everolimus(drug)
- Enrollment
- 96 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2018
Study locations (1)
- Mayo Clinic, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00655655 on ClinicalTrials.govOther trials for Zollinger-Ellison syndrome
Additional recruiting or active studies for the same condition.